DAMAE MEDICAL
Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with the surface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
DAMAE MEDICAL
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2014-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.damae-medical.com
Total Employee:
11+
Status:
Active
Contact:
+33144490410
Email Addresses:
[email protected]
Total Funding:
8.01 M USD
Technology used in webpage:
SPF LetsEncrypt Nginx IPv6 OVH Angular OVH Mail OVH AnyCast
Current Employees Featured
Founder
Investors List
BNP Paribas Développement
BNP Paribas Développement investment in Series A - DAMAE Medical
Kurma Partners
Kurma Partners investment in Series A - DAMAE Medical
Paris-Saclay Seed Fund
Paris-Saclay Seed Fund investment in Series A - DAMAE Medical
BOOST Programs
BOOST Programs investment in Non Equity Assistance - DAMAE Medical
Kurma Partners
Kurma Partners investment in Seed Round - DAMAE Medical
Newsinvest
Newsinvest investment in Seed Round - DAMAE Medical
Idinvest Partners
Idinvest Partners investment in Seed Round - DAMAE Medical
Partech
Partech investment in Seed Round - DAMAE Medical
EIT Digital Accelerator
EIT Digital Accelerator investment in Seed Round - DAMAE Medical
Wilco
Wilco investment in Pre Seed Round - DAMAE Medical
Official Site Inspections
http://www.damae-medical.com
- Host name: 217-160-0-45.elastic-ssl.ui-r.com
- IP address: 217.160.0.45
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "DAMAE Medical"
DAMAE MEDICAL
Damae Medical develops deepLive™ medical device, the new best-in-class imaging system pairing penetration and cellular resolution in 3D. deepLive™ is adapted to the imaging of … See details»
DAMAE Medical - Crunchbase Company Profile & Funding
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection. See details»
Damae Medical 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Damae Medical. Use the PitchBook Platform to explore the full profile. See details»
DAMAE Medical - Forbes
Jun 6, 2025 DAMAE Medical on the 2018 30 Under 30 - Europe - Science & Healthcare - DAMAE Medical has, since Barut and Siret co-founded it with Arnaud Dubois in 2014, See details»
DAMAE MEDICAL Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DAMAE MEDICAL of PARIS 13, ILE DE FRANCE. Get the latest business insights from Dun & … See details»
Damae Medical Company Information - Funding, Investors, and …
Get information on funding, investors, industries, and more for Damae Medical. See Damae Medical company profile and funding data. See details»
☑️DAMAE Medical — Consulting Organization from
DAMAE Medical — Consulting Organization from France with 11-50 employees, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Information & Communication … See details»
Damae Medical - partechpartners.com
Damae has developed an innovative technology called OCTAV, providing dermatologists with a new in vivo imaging modality capable of producing in depth images of the tissue. More than 5 … See details»
DAMAE MEDICAL - VentureRadar
"Damae Medical specializes in developing cutting-edge imaging systems for skin condition diagnosis. Their flagship product, deepLive™, incorporates LC-OCT™ (Line-field Confocal … See details»
DAMAE MEDICAL - Dassault Systèmes
DAMAE Medical is a French startup founded in September 2014, located in Paris. DAMAE Medical’s mission is to improve skin cancer diagnosis through early stage and real time diagnosis. See details»
DAMAE Medical Overview | SignalHire Company Profile
DAMAE Medical is a French innovative start-up founded in 2014 by two engineers and a researcher from the French’s National Centre for Scientific Research. DAMAE Medical … See details»
DAMAE Medical - The Org
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection. See details»
DAMAE MEDICAL - Societe.com
Jun 15, 2025 Finances de DAMAE MEDICAL Score de solvabilité Le score de solvabilité évalue la capacité de remboursement de l'entreprise et donc le risque pour vous d'accorder un prêt … See details»
DAMAE Medical - Funding, Financials, Valuation & Investors
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection. See details»
Damae Medical
Correlatively, DAMAE is developing a full software solution, based on a data storage cloud-platform, a computer-aided software designed to assist dermatologists with OCTAV image … See details»
Series A - DAMAE Medical - 2022-02-03 - Crunchbase
Feb 3, 2022 Overview Organization Name DAMAE Medical Announced Date Feb 3, 2022 Funding Type Series A Funding Stage Early Stage Venture Money Raised obfuscated See details»
Damae Medical Receives FDA Clearance for deepLive
Marking a Major Milestone in Company’s U.S. Market Expansion Plans Paris, France - March 4th, 2025 - Damae Medical, developer of innovative imaging devices and artificial intelligence … See details»
Damae Medical raises €5M in Series A Financing
Damae Medical raises €5M in Series A Financing to accelerate the European deployment of its deepLiveTM platform and revolutionize skin cancer screening, diagnosis and monitoring Press … See details»
DAMAE Medical - Contacts, Employees, Board Members
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection. See details»
Damae Medical Celebrates Milestone: 1st Patient Enrolled in …
Damae Medical Celebrates Milestone: 1st Patient Enrolled in Landmark French Health-Economic Study April 2024 See details»